Business Description
Xvivo Perfusion AB
ISIN : SE0004840718
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 23.28 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.65 | |||||
Interest Coverage | 1.1 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 17.79 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.5 | |||||
3-Year EBITDA Growth Rate | 24.7 | |||||
3-Year EPS without NRI Growth Rate | 51 | |||||
3-Year FCF Growth Rate | -20 | |||||
3-Year Book Growth Rate | 30.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.25 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.16 | |||||
9-Day RSI | 42.8 | |||||
14-Day RSI | 44.71 | |||||
6-1 Month Momentum % | -1.47 | |||||
12-1 Month Momentum % | 12.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.15 | |||||
Quick Ratio | 5.12 | |||||
Cash Ratio | 4.18 | |||||
Days Inventory | 279.42 | |||||
Days Sales Outstanding | 76.19 | |||||
Days Payable | 93.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -0.95 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.74 | |||||
Operating Margin % | 3.6 | |||||
Net Margin % | 4.2 | |||||
FCF Margin % | 8.62 | |||||
ROE % | 1.57 | |||||
ROA % | 1.32 | |||||
ROIC % | 1.04 | |||||
ROC (Joel Greenblatt) % | 18.72 | |||||
ROCE % | 2.29 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 343.83 | |||||
Forward PE Ratio | 94.34 | |||||
PE Ratio without NRI | 343.83 | |||||
Shiller PE Ratio | 1456.49 | |||||
PS Ratio | 14.51 | |||||
PB Ratio | 4.55 | |||||
Price-to-Tangible-Book | 12.53 | |||||
Price-to-Free-Cash-Flow | 166.77 | |||||
Price-to-Operating-Cash-Flow | 166.77 | |||||
EV-to-EBIT | 205.89 | |||||
EV-to-Forward-EBIT | 170.86 | |||||
EV-to-EBITDA | 205.89 | |||||
EV-to-Forward-EBITDA | 66.37 | |||||
EV-to-Revenue | 14.05 | |||||
EV-to-Forward-Revenue | 11.08 | |||||
EV-to-FCF | 164.24 | |||||
Price-to-Projected-FCF | 4.53 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Price-to-Graham-Number | 13.68 | |||||
Price-to-Net-Current-Asset-Value | 15.16 | |||||
Price-to-Net-Cash | 29.75 | |||||
Earnings Yield (Greenblatt) % | 0.49 | |||||
FCF Yield % | 0.58 | |||||
Forward Rate of Return (Yacktman) % | 11.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Xvivo Perfusion AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 50.14 | ||
EPS (TTM) (€) | 0.072 | ||
Beta | 2.72 | ||
Volatility % | 53.14 | ||
14-Day RSI | 44.71 | ||
14-Day ATR (€) | 0.574927 | ||
20-Day SMA (€) | 24.5325 | ||
12-1 Month Momentum % | 12.2 | ||
52-Week Range (€) | 18.52 - 30.2 | ||
Shares Outstanding (Mil) | 31.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Xvivo Perfusion AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Xvivo Perfusion AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Xvivo Perfusion AB Frequently Asked Questions
What is Xvivo Perfusion AB(STU:3XV)'s stock price today?
When is next earnings date of Xvivo Perfusion AB(STU:3XV)?
Does Xvivo Perfusion AB(STU:3XV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |